launched in 2010 to provide greater access to bowel cancer screening.
BowelScreen Australia® uses a clinically proven, sensitive and reliable faecal immunochemical test (FIT).
The Australian designed and manufactured test and accredited pathology services are provided by Clinical Genomics.
Screening using a faecal immunochemical test (FIT) is one of the most effective ways to reduce the risk of bowel cancer.
The Australian Government is gradually phasing in the National Bowel Cancer Screening Program by 2020.
Eligible Australians will receive a free bowel cancer screening test in the mail and are encouraged to complete and return it.
For information regarding start dates of each phase and eligible ages please
visit the National Bowel Cancer Screening (NBCSP) webpage or contact 1800 118 868.
1. GESA, Early Detection, Screening and Surveillance for Bowel Cancer, 2011;
NHMRC, Clinical Practice Guidelines for Surveillance Colonoscopy – in adenoma follow-up; following curative resection of colorectal cancer; and for cancer surveillance in inflammatory bowel disease, 2011.
2. Please note, all results must be sent to a nominated GP. The test cannot be processed without contact details of your GP.